1. Home
  2. VYGR vs JAKK Comparison

VYGR vs JAKK Comparison

Compare VYGR & JAKK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VYGR
  • JAKK
  • Stock Information
  • Founded
  • VYGR 2013
  • JAKK 1995
  • Country
  • VYGR United States
  • JAKK United States
  • Employees
  • VYGR N/A
  • JAKK N/A
  • Industry
  • VYGR Biotechnology: Pharmaceutical Preparations
  • JAKK Recreational Games/Products/Toys
  • Sector
  • VYGR Health Care
  • JAKK Consumer Discretionary
  • Exchange
  • VYGR Nasdaq
  • JAKK Nasdaq
  • Market Cap
  • VYGR 206.9M
  • JAKK 231.8M
  • IPO Year
  • VYGR 2015
  • JAKK 1996
  • Fundamental
  • Price
  • VYGR $3.36
  • JAKK $17.77
  • Analyst Decision
  • VYGR Strong Buy
  • JAKK Strong Buy
  • Analyst Count
  • VYGR 7
  • JAKK 4
  • Target Price
  • VYGR $14.50
  • JAKK $41.75
  • AVG Volume (30 Days)
  • VYGR 725.5K
  • JAKK 102.7K
  • Earning Date
  • VYGR 08-06-2025
  • JAKK 10-29-2025
  • Dividend Yield
  • VYGR N/A
  • JAKK 5.63%
  • EPS Growth
  • VYGR N/A
  • JAKK 25.15
  • EPS
  • VYGR N/A
  • JAKK 3.34
  • Revenue
  • VYGR $42,580,000.00
  • JAKK $684,694,000.00
  • Revenue This Year
  • VYGR N/A
  • JAKK N/A
  • Revenue Next Year
  • VYGR $107.07
  • JAKK $4.01
  • P/E Ratio
  • VYGR N/A
  • JAKK $5.31
  • Revenue Growth
  • VYGR N/A
  • JAKK 1.31
  • 52 Week Low
  • VYGR $2.65
  • JAKK $16.24
  • 52 Week High
  • VYGR $8.28
  • JAKK $35.79
  • Technical
  • Relative Strength Index (RSI)
  • VYGR 49.16
  • JAKK 47.32
  • Support Level
  • VYGR $3.30
  • JAKK $17.75
  • Resistance Level
  • VYGR $3.49
  • JAKK $18.35
  • Average True Range (ATR)
  • VYGR 0.21
  • JAKK 0.53
  • MACD
  • VYGR -0.02
  • JAKK 0.18
  • Stochastic Oscillator
  • VYGR 33.33
  • JAKK 57.28

About VYGR Voyager Therapeutics Inc.

Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.

About JAKK JAKKS Pacific Inc.

Jakks Pacific Inc is a multi-product line, multi-brand toy company that designs, produces, markets, sells and distributes toys and related kid-targeted consumer products, inclusive of kids indoor and outdoor furniture, costumes and various product lines in the sporting goods and home furnishings space. Its products offering include Traditional toys and electronics such as Action figures, Toy vehicles, Dolls and accessories, Ride-on toys, Toys for pets, and others. The company's products have been divided into two segments: (i) Toys/Consumer Products and (ii) Costumes.

Share on Social Networks: